Skip to content

Effectiveness and safety of Yifei Sanjie Granule in people with pulmonary pure ground-glass nodules: a prospective cohort study

Effectiveness and safety of Yifei Sanjie Granule in people with pulmonary pure ground-glass nodules: a prospective cohort study

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100054679
Enrollment
Unknown
Registered
2021-12-23
Start date
2021-08-15
Completion date
Unknown
Last updated
2022-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Pure Ground-glass Nodules

Interventions

Yifei sanjie granule group:None
Simple follow-up group:None

Sponsors

The Third Affiliated Hospital of Henan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with pure ground glass nodules of the lungs by thin-slice (slice thickness 1mm) scan of the chest spiral CT; 2. Aged 18 to 80 years; 3. Good communication and understanding skills; 4. Voluntarily and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with pulmonary pure ground glass nodules who meet surgical indications; 2. Consider metastatic pulmonary nodules; 3. Diffuse pulmonary interstitial lesions, such as interstitial pneumonia, pulmonary fibrosis, etc.; 4. Organ failure caused by diseases of various systems; 5. Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
The growth rate of nodule;The volume doubling time;

Secondary

MeasureTime frame
The largest diameter in the transaxial plane of the nodule;Self-rating Anxiety Scale;Self-rating Depression Scale;Nodule volume;

Countries

China

Contacts

Public ContactLi Jiansheng

The First Affiliated Hospital of Henan University of Chinese Medicine

li_js8@163.com+86 371 66248624

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026